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The syntrophins are modular adapter proteins that function by recruiting signaling molecules to the cytoskeleton via their direct
association with proteins of the dystrophin protein family. We investigated the physiological function of 2-syntrophin by generating a
line of mice lacking this syntrophin isoform. The 2-syntrophin null mice show no overt phenotype, or muscular dystrophy, and form
structurally normal neuromuscular junctions (NMJs). To determine whether physiological consequences caused by the lack of 2-
syntrophin were masked by compensation from the -syntrophin isoform, we crossed these mice with our previously described
-syntrophin null mice to produce mice lacking both isoforms. The /2-syntrophin null mice have NMJs that are structurally more
aberrant than those lacking only -syntrophin. The NMJs of the /2-syntrophin null mice have fewer junctional folds than either parent
strain, and the remaining folds are abnormally shaped with few openings to the synaptic space. The levels of acetylcholine receptors are
reduced to 23% of wild type in mice lacking both syntrophin isoforms. Furthermore, the /2-syntrophin null mice ran significantly
shorter distances on voluntary exercise wheels despite having normal neuromuscular junction transmission as determined by micro-
electrode recording of endplate potentials. We conclude that both -syntrophin and 2-syntrophin play distinct roles in forming and
maintaining NMJ structure and that each syntrophin can partially compensate for the loss of the other.
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Introduction
The syntrophins are a widely expressed family of adapter proteins
that associate with dystrophin and the dystrophin-related pro-
teins utrophin and dystrobrevin. The domain structure of the
syntrophins suggests that they function as adapter proteins that
recruit signaling proteins, channels, and transporters to the
transmembrane dystrophin protein complex. Each of the five
syntrophins (, 1, 2, 1, 2) consists of two pleckstrin homol-
ogy (PH) domains, a postsynaptic density-95/Discs large/zona
occludens (PDZ) domain, and a syntrophin unique (SU) region
(Ahn et al., 1994; Adams et al., 1995; Piluso et al., 2000). The
second PH domain and the SU region form the smallest fragment
known to bind to utrophin (Kachinsky et al., 1999), dystrophin,
and the dystrobrevins (Ahn and Kunkel, 1995). Many proteins
have been identified as syntrophin PDZ domain ligands, includ-
ing neuronal nitric oxide synthase (nNOS) (Brenman et al.,
1996), serine/threonine protein kinases (Hasegawa et al., 1999;
Lumeng et al., 1999), diacylglycerol kinase  (Hogan et al., 2001),
the receptor tyrosine phosphatase-like pancreatic islet protein
ICA512 (Ort et al., 2000), the voltage-gated sodium channels
Nav1.4 and Nav1.5 (Gee et al., 1998; Ou et al., 2003), aquaporin-4
(Neely et al., 2001), the inward rectifier potassium channels Kir
2.2 and Kir 4.1 (Connors et al., 2004; Leonoudakis et al., 2004),
and the ATP-binding cassette transporter A1 (Buechler et al.,
2002).
One example of the physiological function of syntrophin–
ligand interactions occurs in skeletal muscle where the
-syntrophin PDZ domain is required for localization of nNOS
to the sarcolemma (Kameya et al., 1999; Adams et al., 2000,
2001). Disruption of the dystrophin/-syntrophin/nNOS com-
plex by deletion of dystrophin (Thomas et al., 1998),
-syntrophin (Thomas et al., 2003), or just the -syntrophin
PDZ domain (Thomas et al., 2003) results in the failure of skeletal
muscle to attenuate -adrenergic stimulated vasoconstriction
during contraction.
Although all five syntrophins have a similar domain structure
and often bind the same proteins in vitro, they do not necessarily
do so in vivo. For example, - and -syntrophins interact simi-
larly with nNOS in vitro; however, despite their highly conserved
PDZ domain primary structure, neither 1 nor 2 syntrophin
functionally binds nNOS in skeletal muscle (Adams et al., 2000).
These results suggest that each syntrophin has a unique set of
preferred PDZ ligands in vivo. Furthermore, cells often express
more than one syntrophin isoform. In skeletal muscle, four of the
five syntrophin isoforms (, 1, 2, 2) are expressed (Adams et
al., 1993; Ahn et al., 1994; Piluso et al., 2000), with both - and
2-syntrophin present at the postsynaptic neuromuscular junc-
tion (NMJ) (Peters et al., 1994; Kramarcy and Sealock, 2000).
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To investigate the functions of syntrophin in vivo, we previ-
ously generated and characterized mice lacking -syntrophin
(Adams et al., 2000). In addition to the loss of nNOS and
aquaporin-4 in muscle, these mice have aberrant neuromuscular
junctions with sharply reduced levels of acetylcholine receptors
(AChRs) and acetylcholine esterase, undetectable postsynaptic
utrophin, and altered morphology; however, the -syntrophin
null mice show no sign of muscular dystrophy and appear to
function normally under basal laboratory conditions. We there-
fore postulated that another syntrophin is partially compensating
for the loss of -syntrophin.
In this study, we describe the generation of 2-syntrophin
null mice and characterize their neuromuscular junction pheno-
type. We also crossed this mouse line with -syntrophin null
mice and used the /2-syntrophin double-null mice to investi-
gate the extent to which one syntrophin can compensate for the
loss of the other. We show that mice lacking both syntrophin
isoforms have a more severe phenotype than mice lacking only
one syntrophin.
Materials and Methods
Generation of 2-syntrophin null mice. We have previously characterized
the gene encoding mouse 2-syntrophin isolated from a genomic library
derived from 129Sv DNA (Adams et al., 1995). A targeting vector was
constructed by cloning a 3 kb EcoRI/Ec 47 restriction fragment from the
region 5 of exon 1 and a 3 kb XhoI fragment from intron 1 into the
plasmid JNS2 (Dombrowicz et al., 1993) (see Fig. 1). The resulting re-
combinant gene is missing the entire first exon (amino acids 1–173,
which encode half of the first PH domain and the entire PDZ domain),
0.5 kb of 5 flanking sequence, and 0.3 kb of the first intron. The targeting
vector was linearized with NotI and transferred to embryonic day 14
embryonic stem (ES) cells by electroporation. After selection with G418
and gancyclovir (a gift from Roche Biosciences, Palo Alto, CA), homol-
ogous recombinant ES cells were identified by Southern blotting and
used for C57BL/6 blastocyst injection performed by the University of
North Carolina Embryonic Stem Cell Facility. Chimeras were bred with
C57BL/6 females, and germline transmission was confirmed by Southern
blot analysis. The mice used in this study either were first generation with
a mixed 129Sv/C57BL/6 background or have been bred back against
C57BL/6 for a minimum of five generations. Mice with either back-
ground show similar phenotypes.
Southern analysis. Genomic DNA was isolated from mouse tail biop-
sies using a QIAmp tissue kit (Qiagen, Valencia, CA), digested with XbaI,
and resolved on a 1% agarose gel. GenScreen (DuPont NEN, Boston,
MA) replicas were incubated with radiolabeled probe as described pre-
viously (Adams et al., 1995).
Antibodies. We have previously characterized the following antibodies:
pan-specific syntrophin monoclonal antibody (mAb) SYN1351 (Froeh-
ner et al., 1987); isoform specific syntrophin polyclonal antibodies
(pAbs) SYN17 (-syntrophin), SYN28 (2-syntrophin), and SYN37
(1-syntrophin) (Peters et al., 1997); pAb 1862 (utrophin) (Kramarcy et
al., 1994); pAb 2723 (C terminus of dystrophin) (Kramarcy et al., 1994);
dystrobrevin Abs 638 (-dystrobrevin-1), and D2 (-dystrobrevin-2)
(Peters et al., 1998). The sodium channel antibody was a gift from S. Rock
Levinson (University of Colorado Health Sciences Center). The poly-
clonal antibody to nNOS was purchased from Diasorin Inc. (Minneap-
olis, MN), and the neurofilament antibody was from Sigma-Aldrich (St.
Louis, MO).
Immunoblotting. Muscle protein extracts
were prepared as described previously (Peters et
al., 1997). Syntrophin complex was isolated by
incubating the extract with the pan syntrophin
mAb 1351 followed by precipitation with pro-
tein G-coated beads (Sigma). The resulting pel-
lets were resuspended in SDS-PAGE sample
buffer, subjected to electrophoresis on a 10%
polyacrylamide tricine-buffered gel, transferred
to Immobilon-P membrane (Millipore, Bed-
ford, MA), and incubated with the syntrophin
isoform-specific antibodies as described previ-
ously (Peters et al., 1997).
Fluorescence microscopy. Immunofluores-
cence labeling of cross sections was performed
on unfixed quadriceps muscle using 8 m cryo-
sections as described (Peters et al., 1998).
For en face views, 40 m cryosections of ster-
nomastoid muscle were incubated with Alexa
488 -bungarotoxin (Molecular Probes, Eu-
gene, OR) to visualize AChRs. Confocal mi-
Figure 1. Generation of 2-syntrophin null mice. A, Schematic diagram of the construct
used for targeted recombination of the 2-syntrophin gene. The first exon, 0.5 kb of 5 flanking
region, and 336 base pairs of intron 1 were deleted and replaced with the neomycin resistance
gene. B, Southern blot analysis of mice homozygous for wild type (BB), heterozygous (Bb), and
homozygous null for 2-syntrophin (bb). Genomic DNA was digested with restriction enzyme
XbaI and probed with DNA from the area indicated in A. C, Immunoblot analysis of muscle
extracts from wild-type (BB) and 2-syntrophin null mice (bb) using syntrophin isoform-
specific antibodies.
Figure 2. 2-syntrophin is absent from the postsynaptic neuromuscular junction. Immunofluorescence of the neuromuscular
junction of 2-syntrophin null mice shows absence of 2-syntrophin but no substantial upregulation of - or 1-syntrophin.
Scale bar, 5 m.
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croscopy was performed using a Leica TCS NT microscope either at the
University of North Carolina (Chapel Hill, NC) or at the W. M. Keck
Center for Advanced Studies in Neural Signaling (University of Wash-
ington, Seattle, WA). A Zeiss Axioskop with Axiocam was used to capture
images for determining fluorescence intensity and for imaging the
hematoxylin– eosin-stained tissue.
Fluorescence intensity quantification of labeled AChRs. Sternomastoid
muscle AChRs were labeled with Alexa 488 -bungarotoxin, and NMJs
lying fully in the 40 m section were digitally captured using identical
settings for control and syntrophin null samples. Variations in section
labeling were minimized by simultaneously labeling control and syntro-
phin null samples. Variations in excitation lamp intensity were mini-
mized by capturing images of each syntrophin null sample and corre-
sponding control sample on the same day. After the digital image of each
NMJ was circumscribed using Adobe Photoshop, the difference between
the average pixel intensity in the circumscribed area and average back-
ground pixel intensity of the corresponding muscle fiber was deter-
mined. The product of this difference and the number of circumscribed
pixels gave a total AChR specific intensity measure for each NMJ.
Electron microscopy. Sternomastoid muscles were prepared for elec-
tron microscopy, and the nerve–muscle contacts in every NMJ encoun-
tered were imaged in only a single plane as described (Adams et al., 2000).
Each nerve contact was analyzed by counting the number of junctional
fold openings to the synaptic cleft and dividing by the total length of
presynaptic membrane immediately apposed to the muscle cell (open-
ings per micrometer). Virtually identical results were obtained by aver-
aging this parameter over all contacts, regardless of their lengths, and by
using a length-weighted average to avoid possible skewing of the result by
the numerous small, possibly immature contacts.
Mouse running wheels. Equal numbers of wild-type and null mice (four
each for -syntrophin null; six each for 2-syntrophin null and /2-
syntrophin null) were individually caged with access to a running wheel
(Nalgene). The distance run voluntarily was monitored using standard
bicycle speedometers (Specialized, Morgan Hill, CA) calibrated for the
wheel size. Each set of mice was monitored for 8 –10 weeks. For each
syntrophin null mouse, the distance run per week was divided by the
mean distance run by the control mice over the same week and multi-
plied by 100 to obtain the percentage of control.
Microelectrode recording. Endplate potentials (EPPs) and miniature
endplate potentials (MEPPs) were recorded from diaphragm muscles of
three control and syntrophin null mice at 30°C and corrected for a mem-
brane potential of 80 mV. Miniature endplate currents (MEPCs) were
recorded at room temperature with the membrane potential clamped at
80 mV (Engel et al., 1993). The quantal content of the EPP was esti-
mated with correction for nonlinear summation and non-Poisson re-
lease. Stimulation was at 0.5 Hz. The initial 50 stimuli were discarded,
and the next 64 were analyzed by the variance method (Nagel et al.,
1990).
Results
Disruption of the -syntrophin gene produced mice exhibiting
structurally abnormal neuromuscular junctions with reduced
levels of acetylcholine receptors and acetylcholine esterase and
complete absence of detectable postsynaptic utrophin (Adams et
al., 2000). Because 2-syntrophin has 43% amino acid identity
to -syntrophin and is highly localized at the NMJ postsynaptic
membrane where, like -syntrophin, it is present both at the
AChR-rich crest and in the junctional folds (Peters et al., 1994;
Kramarcy and Sealock, 2000), we hypothesized that this isoform
may compensate to some extent for the loss of -syntrophin. To
examine this possibility, we used gene disruption technology to
generate mice lacking 2-syntrophin (Fig. 1).
Generation and characterization of 2-syntrophin null mice
The targeted gene disruption removed the entire first exon, 0.5 kb
of 5 flanking sequence and 0.3 kb of the first intron (Fig. 1A).
Genomic DNA from the first generation of mice was analyzed by
Southern blot and gave bands of the predicted size, demonstrat-
ing that the 2-syntrophin gene was disrupted (Fig. 1B). Off-
spring of the founding heterozygotes were genotyped and found
to occur at the expected Mendelian ratio of 1:2:1 (wild type/
Figure 3. Muscle histology. Hematoxylin– eosin staining of mouse quadriceps muscle
shows no evidence of muscle pathology in mice lacking 2-syntrophin (bb) or both - and 2-
syntrophin (aabb). Scale bar, 50 m.
Figure 4. Acetylcholine receptor levels in syntrophin null mice. Images of sternomastoid
muscle NMJs labeled with fluorescent -bungarotoxin were captured under identical condi-
tions using a 40 objective and used to determine the relative levels of AChRs in control and
syntrophin null mice. Error bars indicate SEM.
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heterozygote/null) and therefore showed no evidence of embry-
onic lethality.
Using antibodies known to bind well downstream of exon
I-encoded sequence (Peters et al., 1997; Adams et al., 2001), we
confirmed the absence of 2-syntrophin at the protein level by
performing immunoblots on muscle preparations enriched for syn-
trophins (Fig. 1C). Immunofluorescence studies of 2-syntrophin
null skeletal muscle confirmed that 2-syntrophin is absent from the
postsynaptic membrane, its predominant site of expression in mus-
cle cells (Fig. 2). The loss of 2-syntrophin does not appear to affect
the levels or distribution of postsynaptic -syntrophin or 1-
syntrophin at the NMJ. -Syntrophin is present at both the crest and
depths of the junctional folds, a distribution similar to that seen in
wild-type mice. 1-syntrophin remains presynaptic at the 2-
syntrophin null NMJ, as it is in wild-type mice, and is not upregu-
lated postsynaptically in these adult mice (Fig. 2).
The 2-syntrophin null mice have no overt phenotype. They
are motile and fertile and live up to 2 years under laboratory
conditions. Because 2-syntrophin associ-
ates directly with members of the dystro-
phin protein family, we examined the
muscle for any dystrophic phenotype.
Overall muscle structure as assessed by he-
matoxylin– eosin staining did not appear
different from that of wild-type controls
(Fig. 3). We saw no sign of significant mus-
cle fibrosis or regeneration. Numbers of
central nuclei were similar for controls and
the 2-syntrophin null mice (data not
shown).
Generation and characterization of mice
lacking both -syntrophin
and 2-syntrophin
To investigate the possibility that -syn-
trophin and 2-syntrophin could compen-
sate for each other when one is absent, we
bred the -syntrophin null mouse with the
2-syntrophin null to generate /2-
syntrophin double-null mice. Like the par-
ent strains, the /2-syntrophin null mice
are motile and fertile and show no overt phe-
notype. Furthermore, hematoxylin–eosin
staining of the /2-syntrophin null muscle
revealed no indications of muscular dystro-
phy (Fig. 3).
Molecular characterization of NMJs
In -syntrophin null muscle, junctional
AChR levels are reduced to 35% of normal
levels, and the AChR is distributed over ab-
normally shallow synaptic gutters, with un-
usual fingers of AChR extending outside the
gutters (Adams et al., 2000). We used en face
images of -bungarotoxin-labeled NMJs to
assess the 2- and /2-syntrophin null
mice with respect to these characteristics.
The 2-syntrophin null NMJs have
AChR levels slightly higher than those of
control C57BL/6 mice (mean, 115% of
wild type; p  0.02). The observed increase
in fluorescence intensity of the 2-
syntrophin null NMJs appears to be
caused mainly by a brighter labeling of the lateral edges, suggest-
ing a slightly deeper neural groove. The distribution of AChR was
normal (Fig. 4). Mice lacking both syntrophin isoforms express
levels of AChRs significantly lower ( p  0.001) than those of the
-syntrophin null (mean, 23% of wild type), and the derange-
ment of the AChR distribution is profound (Fig. 5), ranging from
at least as significant as in the -syntrophin null mouse to even
more striking. In the latter case, broad fields of AChR organized
in dots, short streaks, and fingers, with little hint of a synaptic
gutter, and smaller, poorly formed patches of AChR that vary
greatly in size and staining intensity are common. Most, but not
all, of the small AChR accumulations are innervated (Fig. 5). In
common with the most deranged regions of -syntrophin null
NMJs, all of these AChR distributions label weakly or not at all
with the lectin Vicia villosa-B4, a marker for junctional folds
(data not shown). These observations suggest the presence of
immature contacts and possibly a high rate of synaptic
remodeling.
Figure 5. AChR distributions and innervation. NMJs in sternomastoid muscle labeled for AChR (green) and neurofilament (NF)
(red). Top row, NMJs in 2-syntrophin null mice (AAbb) are essentially identical to wild-type controls except as noted in Figure 4. Middle
row, /2-syntrophin double-null (aabb) NMJ showing large fields of AChR organized in dots, streaks, and fingers, plus several smaller
patches of variable, lower-density AChR (left panel, arrows). Nerve branches going to such patches are often not apparent (middle panel,
arrows). Bottom row, NMJs in the -syntrophin null mouse (aaBB) appear to be less severely altered than in the double-null mice.
Microscope parameters were adjusted to give similar maximum intensities of AChR image, despite the much lower AChR densities in the
-syntrophin null NMJs. Scale bars: top row, 13.9 m; middle row, 15 m; bottom row, 12.5 m.
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Both - and 2- syntrophin are known
to bind to members of the dystrophin pro-
tein family present at the NMJ, and, in
principle, these associations could be es-
sential for incorporation of these proteins
at the NMJ. This idea was confirmed in the
-syntrophin null mouse, where the ab-
sence of -syntrophin entrains elimina-
tion of utrophin from NMJs, without
change in dystrophin at the NMJ or on the
sarcolemma (Adams et al., 2000). We
therefore investigated the distributions of
proteins that interact with syntrophins in
the NMJs of the 2- and /2-syntrophin
null mice. In the 2-syntrophin null mice,
dystrophin, utrophin, and dystrobrevin
show distributions similar to those of con-
trol mice (Fig. 6). In particular, utrophin is
present at normal levels and colocalized
precisely with AChRs. Similarly, localization
of dystrophin and dystrobrevin remain es-
sentially unperturbed in mice lacking both
- and 2-syntrophin. Observed minor dif-
ferences are likely caused by the structural
alterations discussed below. Utrophin is ab-
sent from the postsynaptic NMJ in the /2-
syntrophin double-null mice (Fig. 6A).
In vitro, the PDZ domains of both -
and 2-syntrophin bind to nNOS and the
voltage-gated sodium channel, two signal-
ing proteins present at the NMJ (Brenman
et al., 1996; Gee et al., 1998). Mice lacking
-syntrophin lose the ability to localize
nNOS at the sarcolemma and the NMJ de-
spite the presence of 2-syntrophin (Ad-
ams et al., 2000). As expected, nNOS is also
absent in the /2-syntrophin double-
null mice, but in the absence of only 2-
syntrophin it remains concentrated on the
postsynaptic membrane (Fig. 6B). The
distribution of the voltage-gated sodium
channels, Nav 1.4 and Nav1.5, appears un-
affected by the absence of either or both
syntrophin isoforms (Fig. 6B).
Postsynaptic folds of syntrophin
null mice
In wild-type NMJs, the junctional folds are basal lamina-lined
folds of the postsynaptic membrane that are oriented more or less
radially relative to the synaptic cleft and open to the cleft through
most of their extent (Fig. 7B). In the -syntrophin null mouse,
the folds are plentiful but often misoriented relative to the surface
and sometimes fragmented (Adams et al., 2000). Even those ori-
ented toward the synaptic cleft are often not open to the cleft in
any single image. A quantitative indication of this disorganiza-
tion was given by the number of junctional fold openings to the
synaptic cleft per micrometer of nerve–muscle contact; this pa-
rameter was reduced by 70% in the -syntrophin null mouse
relative to littermate controls (Adams et al., 2000). In the 2-
syntrophin null mouse, the appearance of the folds was normal
(Fig. 7A), and the number of openings in randomly selected sin-
gle images of nerve–muscle contacts was not different from con-
trol (average of four mice  2.31 openings per micrometer com-
pared with 2.34 for one littermate wild-type mouse and 2.35 for a
C57BL/6 control). An effect was apparent, however, when the 2-
syntrophin null condition was placed on the -syntrophin null
background. The deficit of openings, even when numerous folds
were present, was striking (Fig. 7C,D), and openings per micrometer
were reduced by 90%, from 2.00 and 2.19 in two control mice to 0.19
and 0.16 in two /2-syntrophin null mice. Results of a qualitative
examination of a third mouse were similar, i.e., the majority of
nerve–muscle contacts showed no fold openings. The quantitative
data for the three genotypes are summarized in Figure 7E. As in the
-syntrophin null and wild-type mice, all junctional folds in the
/2-syntrophin null mice contained basal lamina (Fig. 7), and
staining with tannic acid during fixation showed that they commu-
nicate with the extracellular space (data not shown). The location at
which that communication takes place is not visible in most sections.
Figure 6. Syntrophin-associated proteins at the neuromuscular junction of syntrophin null mice. Composite images of the
indicated dystrophin family proteins (red) and AChR (green). Note that utrophin is lost from the postsynaptic membrane only
when -syntrophin is absent. The absence of 2-syntrophin does not affect the distribution of the dystrophin family proteins. B,
Composite images of nNOS or sodium channels (NaCh) (red) and AChR (green). nNOS remains present at the NMJ of the 2-
syntrophin null mice but is lost when no -syntrophin is present. Sodium channel distribution is unaffected by the loss of
-syntrophin, 2-syntrophin, or both syntrophin isoforms. Scale bar, 5 m.
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Electron microscopy also showed that the NMJs of the /2-
syntrophin null mice often had numerous small terminals or
axon branches in addition to terminals of normal adult appear-
ance (Fig. 7). The interaction of these terminals with the accom-
panying Schwann cells was often complex,
whereas the interaction with the muscle
cell surface tended to be simple, with no or
only a very shallow synaptic gutter, even
when folds were present. These apparently
immature contacts reinforce the sugges-
tion that remodeling is a characteristic of
these mice.
Voluntary exercise in the syntrophin
null mice
As a functional test of whole-animal phys-
iology, mice were caged individually with
free access to a running wheel. Wheel rev-
olutions and the calculated distance run
were monitored simultaneously for con-
trol and syntrophin null mice (Fig. 8).
Mice lacking -syntrophin (Adams et al.,
2000) or 2-syntrophin ran distances sim-
ilar to those of the control mice (Fig. 8);
however, mice lacking both - and 2-
syntrophin ran only about half the dis-




To determine whether the running
deficit of mice lacking both - and 2-
syntrophin was caused by a functional
defect of neuromuscular transmission, we
performed electrophysiological compari-
sons of the mutant and normal mice (Ta-
ble 1). A small but statistically significant
decrease of the MEPP amplitude in both
mouse lines lacking -syntrophin was ob-
served. Furthermore, the MEPC ampli-
tude was significantly decreased in the
/2-syntrophin null mouse. The double
syntrophin null mice also had significantly
decreased decay time constants for both
MEPPs and MEPCs. The number of transmitter quanta released
by nerve impulse in the syntrophin null mice (both single and
double mutants) was not significantly different from that of the
control mice. Thus, the running deficiency is most likely not
caused by defects in neuromuscular junction transmission.
Discussion
The syntrophins are modular proteins that recruit signaling mol-
ecules to the cytoskeleton via their direct association with pro-
teins of the dystrophin family. We have previously investigated
the physiological significance of this function in vivo by generat-
ing a line of mice lacking -syntrophin (Adams et al., 2000).
These mice fail to properly localize aquaporin-4 and nNOS to the
muscle sarcolemma and utrophin to the postsynaptic membrane
of the neuromuscular junction. Furthermore, they have structur-
ally aberrant neuromuscular junctions with a shallow neural
groove, radiating fingers of AChR, and reduced levels of both the
AChR and acetylcholinesterase (Adams et al., 2000). In this study,
we used a similar approach to investigate the in vivo function of
2-syntrophin in skeletal muscle by generating a line of mice
lacking this syntrophin isoform. We then investigated the degree
to which the  and 2 isoforms of syntrophin can compensate for
Figure 7. Electron microscopy of junctional folds. A, Nerve–muscle contacts in a 2-syntrophin null mouse and its wild-type
littermate ( B) show numerous, well organized junctional folds and associated openings to the synaptic cleft. C, D, Nerve–muscle
contacts from /2-syntrophin null mice. C, A nerve–muscle contact of mature appearance. Approximately 20 fold-like struc-
tures are shown. Many are disorganized (left two-thirds of the image), but even where they are reasonably organized (right
one-third), there are no openings to the synaptic cleft in the section shown. D, A contact of immature appearance. Disorganized
fold structures are apparent just below the muscle cell surface. The central dark stripes within the fold structures in C and D are
basal lamina. Scale bar: A, 2.5 m; B, 1.8 m; C, 1.2 m; D, 1.0 m. E, The values for openings to the synaptic cleft per
micrometer of presynaptic membrane for all nerve–muscle contacts are grouped by bins of 0.5 for two /2-syntrophin null mice
(this study) and -syntrophin null mice and their wild-type littermates (Adams et al., 2000).
Figure 8. Voluntary exercise on running wheels in the syntrophin null mice. Mice lacking
both - and 2-syntrophin ran significantly less ( p  0.01) on voluntary running wheels than
mice lacking only one of the syntrophin isoforms. Error bars indicate SEM.
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the loss of the other by generating mice lacking both of these
syntrophins.
2-Syntrophin null mice
The 2-syntrophin null mice showed no apparent muscle phe-
notype, except possibly elevated AChR number at neuromuscu-
lar junctions; however, we cannot exclude the possibility that
they may have a non-muscle phenotype. 2-Syntrophin is widely
expressed and interacts with various signaling molecules in other
tissues. These include the tyrosine phosphatase-like ICA512 in
pancreas (Ort et al., 2000), the ATP-binding cassette transporter
A1 in liver (Buechler et al., 2002), and the syntrophin-associated
serine/threonine kinase in brain (Lumeng et al., 1999). Because
the 2-syntrophin null mice live a normal lifespan (at least in the
laboratory setting), however, these interactions must not be re-
quired for survival.
/2-Syntrophin double-null mice
a-Syntrophin and 2-syntrophin have similar protein domain
organizations and are both present at the NMJ. Because they
share overlapping but not identical distributions, it is plausible
that one isoform could partially compensate for the loss of the
other. To test this possibility, we crossed the -syntrophin null
mice with the 2-syntrophin null mice to produce /2-
syntrophin double-null mice. Like their parent strains, the dou-
ble syntrophin null mice show no indications of muscular dys-
trophy; however, the double syntrophin null mice run
significantly less (50%) on voluntary exercise wheels than wild-
type mice or either parent strain. Because we observed no damage
to the muscle fiber using histology techniques, we investigated
the possibility that the double syntrophin null mice run less be-
cause of a deficit in neuromuscular transmission. Quantal release
by nerve impulse was not significantly different among control
(C57BL/6), -syntrophin null, and /2-syntrophin null mice.
We did observe, however, a small but significant decrease in the
amplitude of MEPP in the -syntrophin null and the /2-
syntrophin null mice and a decrease of the MEPC in the /2-
syntrophin null mice. We also observed a decrease in the MEPP
and MEPC decay time constants in both mouse lines lacking
-syntrophin, suggesting either faster channel closure or perhaps
faster destruction of acetylcholine by acetylcholine esterase at-
tributable to changes in endplate geometry. These small changes
in the MEPP and MEPC are not sufficient to explain the reduced
level of voluntary running in the /2-syntrophin double-null
mice. The running deficit may be caused by a non-muscle defect,
perhaps affecting metabolism or neuronal function.
The /2-syntrophin null mice have neuromuscular junction
structural defects similar in nature but more severe than those
observed in the -syntrophin null mice. En face views of the
/2-syntrophin null NMJs show more extensive branching of
the radiating fingers of AChRs than those of the -syntrophin
null (Fig. 5). Furthermore, the synaptic levels of receptor are even
lower in the /2-syntrophin null mice (23% of wild type) com-
pared with the -syntrophin null mice (35% of wild type) (Fig.
4). The junctional folds are also more aberrant in the /2-
syntrophin null mice, with fewer synaptic cleft openings per mi-
crometer of nerve contact (Fig. 7). These abnormalities in NMJ
structure occur despite the presence of normal levels of dystro-
phin, dystrobrevin, and sodium channels.
Syntrophin isoform compensation
We observed here that NMJ defects in the /2-syntrophin
double-null mice are more severe than in the -syntrophin null
mice and that deficiencies in voluntary running appear only
when both - and 2-syntrophin are absent. These observations
suggest that these two syntrophins can compensate for each other
in at least some activities at the NMJ. This compensation could be
expected, given the high degree of sequence similarity in this
family and similar behaviors in some biochemical measures. On
the other hand, mechanisms in which compensation does not
occur are known. For example, the 2-syntrophin PDZ domain
binds syntrophin-associated serine/threonine kinase and
microtubule-associated serine/threonine kinase in vitro, but the
-syntrophin PDZ domain does not (Lumeng et al., 1999). nNOS
is absent from synapses in -syntrophin null muscle, despite the
presence of 2-syntrophin (Adams et al., 2000), and the loss of
2-syntrophin alone has no detectable effect on the level of synaptic
nNOS. The same applies to 1-syntrophin on the sarcolemma. In
the absence of -syntrophin, 1-syntrophin cannot retain nNOS (or
aquaporin-4) on the membrane, even when present at higher than
normal amounts (Adams et al., 2001). Sarcolemmal nNOS retention
is known to depend critically on interaction of the nNOS and
-syntrophin PDZ domains (Adams et al., 2001) but may also re-
quire other, less clearly defined interactions within the dystrophin
complex (Rafael et al., 1994; Chao et al., 1996). Because the PDZ
domains of all three syntrophins bind the nNOS PDZ domain in
vitro, the requirement for only -syntrophin presumably reflects in
vivo regulatory processes that are absent in vitro.
Clearly, both - and 2-syntrophin play an important role in
NMJ synapse formation and/or maintenance. Furthermore, our re-
sults indicate that these two syntrophins can only partially compen-
sate for the loss of the other isoform. Finally, the running wheel data
coupled with the neuromuscular transmission experiments suggest
that the syntrophins have important roles outside of the neuromus-
cular junction. Studies of -syntrophin in the brain, aided by the
availability of the -syntrophin null mouse, have revealed a critical
role in the expression and regulation of aquaporin-4 in astroglial end
feet. Further investigation of the 2-syntrophin null mouse may
prove similarly informative.
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